Market Tracker

01/20 5:16pm ET

Novo Nordisk A/S (NYSE:NVO)

35.53
Delayed Data
As of Jan 20
 -0.10 / -0.28%
Today’s Change
30.89
Today|||52-Week Range
57.81
-0.92%
Year-to-Date
7 Stocks for 2017
Jan 20 / GuruFocus News - Paid Partner Content
Novo Nordisk (NVO) Fiasp Gets EU Nod for Diabetes in Adults
Jan 11 / Zacks.com - Paid Partner Content
Gw Henssler & Associates Ltd Buys iShares MSCI EAFE, Novo Nordisk A/S, SPDR S&P 500, ...
Jan 17 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close35.63
Today’s open35.63
Day’s range35.52 - 35.73
Volume1,743,767
Average volume (3 months)3,832,610
Market cap$69.7B
Dividend yield2.55%
Data as of 4:02pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)--
Earnings growth (next 5 years)+8.15%
Revenue growth (last year)+1.43%
P/E ratio2.4
Price/Sales9.38
Price/Book13.24

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.06+0.15%
AZNAstraZeneca-0.84-3.01%
AGNAllergan-0.24-0.11%
BMYBristol-Myers Squibb-6.26-11.28%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateFebruary 2, 2017
EPS forecast (this quarter)$0.51
Annual revenue (last year)$16.0B
Annual profit (last year)$5.2B
Net profit margin32.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts